Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness

Completed · Phase 3 · Has a placebo group

Conditions studied: Venous Thrombosis, Pulmonary Embolism

In brief

The purpose of this study is to learn if apixaban can prevent blood clots in the leg (deep vein thrombosis \[DVT\]) and lung (pulmonary embolism \[PE\]) that sometimes occur within patients hospitalized for acute medical illness, and to learn how apixaban compares to enoxaparin (Lovenox®) for preventing these clots. The safety of apixaban will also be studied.

Key facts

Study ID
NCT00457002
Run by
Bristol-Myers Squibb
People needed
6758
Starts
2007-06-01
Expected to finish
2011-05-01
Last updated by the study team
2015-12-08

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.